← Back to Search

iMD for Quitting Smoking in Cancer Patients

N/A
Recruiting
Led By Janice Tsoh, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or order
Started the CT simulation procedure (about to initiate radiation therapy) or currently receiving radiation treatment for cancer at a University of California, San Francisco (UCSF) location (Mission Bay, Mount Zion, Parnassus, etc.).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months
Awards & highlights

Study Summary

This trial will help develop and test an educational tool, called an interactive Mobile Doctor (iMD), to engage cancer patients receiving radiation therapy in quitting or staying tobacco-free.

Who is the study for?
This trial is for adults who can consent to participate, understand the study, and will follow it through. They must have used tobacco in the past year and be starting or currently receiving radiation therapy for cancer at UCSF. People with contraindications, cognitive or medical issues as judged by their care team, hearing/vision disabilities affecting intervention participation, or those already done with radiation therapy cannot join.Check my eligibility
What is being tested?
The study is testing an educational video tool called Interactive Mobile Doctor (iMD) designed to help cancer patients undergoing radiation at UCSF quit smoking or maintain abstinence from tobacco use during their treatment.See study design
What are the potential side effects?
Since iMD is a non-invasive educational tool rather than a medication, traditional side effects are not expected. However, participants may experience discomfort discussing smoking habits or stress related to quitting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am starting or currently undergoing radiation therapy for cancer at a UCSF location.
Select...
I understand and can follow the study's procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median scores on the perceived helpfulness of the iMD program
Proportion of eligible individuals who consent to enroll in the study
Proportion of iMD participants who complete 2 or more sessions
+1 more
Secondary outcome measures
Proportion of iMD participants who indicate requests of referral for smoking cessation
Proportions of participants with reported abstinence

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interactive Mobile Doctor (iMD) InterventionExperimental Treatment1 Intervention
Participants will receive up to a total of 3 iMD sessions prior to their completion of radiation therapy; each session will take about 10-15 minutes and includes: 1) computerized assessments that will be delivered on the screen via text with accompanying audio and participants will respond directly on the tablet 2) tailored videos that deliver messages specific to patient's responses to selected assessment questions and 3) a summary printout
Group II: Control GroupActive Control1 Intervention
Participants will complete questionnaires and receive a handout containing tobacco cessation resources.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,503 Previous Clinical Trials
15,236,575 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,538 Total Patients Enrolled
Janice Tsoh, PhDPrincipal InvestigatorUniversity of California, San Francisco
7 Previous Clinical Trials
3,188 Total Patients Enrolled

Media Library

Interactive Mobile Doctor (iMD) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05021185 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on the amount of individuals taking part in this clinical experiment?

"Affirmative, clinicaltrials.gov states that this research is actively recruiting participants. The trial was launched on November 15th 2022 and the latest update occured on November 29th 2022. A total of 80 volunteers are needed from a single location for successful completion of the study."

Answered by AI

Are there opportunities to participate in this research experiment currently available?

"Indeed, the clinicaltrials.gov registry confirms that this medical experiment is currently searching for participants. It was first listed on November 15th 2022 and has been revised as recently as November 29th 2022. This trial requires recruiting 80 patients from a singular location."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
~48 spots leftby May 2026